Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2016

Open Access 01-12-2016 | Study protocol

An organisational change intervention for increasing the delivery of smoking cessation support in addiction treatment centres: study protocol for a randomized controlled trial

Authors: Billie Bonevski, Ashleigh Guillaumier, Anthony Shakeshaft, Michael Farrell, Flora Tzelepis, Scott Walsberger, Catherine D’Este, Chris Paul, Adrian Dunlop, Andrew Searles, Peter Kelly, Rae Fry, Robert Stirling, Carrie Fowlie, Eliza Skelton

Published in: Trials | Issue 1/2016

Login to get access

Abstract

Background

The provision of smoking cessation support in Australian drug and alcohol treatment services is sub-optimal. This study examines the cost-effectiveness of an organisational change intervention to reduce smoking amongst clients attending drug and alcohol treatment services.

Methods/design

A cluster-randomised controlled trial will be conducted with drug and alcohol treatment centres as the unit of randomisation. Biochemically verified (carbon monoxide by breath analysis) client 7-day-point prevalence of smoking cessation at 6 weeks will be the primary outcome measure. The study will be conducted in 33 drug and alcohol treatment services in four mainland states and territories of Australia: New South Wales, Australian Capital Territory, Queensland, and South Australia. Eligible services are those with ongoing client contact and that include pharmacotherapy services, withdrawal management services, residential rehabilitation, counselling services, and case management services. Eligible clients are those aged over 16 years who are attending their first of a number of expected visits, are self-reported current smokers, proficient in the English language, and do not have severe untreated mental illness as identified by the service staff. Control services will continue to provide usual care to the clients. Intervention group services will receive an organisational change intervention, including assistance in developing smoke-free policies, nomination of champions, staff training and educational client and service resources, and free nicotine replacement therapy in order to integrate smoking cessation support as part of usual client care.

Discussion

If effective, the organisational change intervention has clear potential for implementation as part of the standard care in drug and alcohol treatment centres.

Trial registration

Australian and New Zealand Clinical Trials Registry, ACTRN12615000204​549. Registered on 3 March 2015.
Appendix
Available only for authorised users
Literature
1.
Baker A, Ivers RG, Bowman J, Butler T. Where there’s smoke, there’s fire: high prevalence of smoking among some sub-populations and recommendations for intervention. Drug Alcohol Rev. 2006;25(1):85–96.CrossRefPubMed
2.
Kelly PJ, Baker AL, Deane FP, Kay‐Lambkin FJ, Bonevski B, Tregarthen J. Prevalence of smoking and other health risk factors in people attending residential substance abuse treatment. Drug Alcohol Rev. 2012;31(5):638–44.CrossRefPubMed
3.
Australian Institute of Health and Welfare. National Drug Strategy Household Survey Report. Canberra: AIHW 2014 Contract No.: Cat. no. PHE 183; 2013.
4.
5.
Cookson C, Strang J, Ratschen E, Sutherland G, Finch E, Mcneill A. Smoking and its treatment in addiction services: clients’ and staff behaviour and attitudes. BMC Health Serv Res. 2014;14(1):304.CrossRefPubMedPubMedCentral
6.
7.
Department of Health. Smoking kills: a white paper on tobacco. London: The Stationary Office; 1998.
8.
Prochaska JJ. Failure to treat tobacco use in mental health and addiction treatment settings: a form of harm reduction? Drug Alcohol Depend. 2010;110(3):177–82.CrossRefPubMedPubMedCentral
9.
Randall D, Degenhardt L, Vajdic CM, Burns L, Hall WD, Law M, et al. Increasing cancer mortality among opioid‐dependent persons in Australia: a new public health challenge for a disadvantaged population. Aust N Z J Public Health. 2011;35(3):220–5.CrossRefPubMed
10.
Prochaska JJ, Rossi JS, Redding CA, Rosen AB, Tsoh JY, Humfleet GL, et al. Depressed smokers and stage of change: implications for treatment interventions. Drug Alcohol Depend. 2004;76(2):143–51.CrossRefPubMed
11.
Burling TA, Seidner Burling A, Latini D. A controlled smoking cessation trial for substance-dependent inpatients. J Consult Clin Psychol. 2001;69(2):295.CrossRefPubMed
12.
Joseph AM, Willenbring ML, Nugent SM, Nelson DB. A randomized trial of concurrent versus delayed smoking intervention for patients in alcohol dependence treatment. J Stud Alcohol. 2004;65(6):681.CrossRefPubMed
13.
Kalman D, Hayes K, Colby SM, Eaton CA, Rohsenow DJ, Monti PM. Concurrent versus delayed smoking cessation treatment for persons in early alcohol recovery: a pilot study. J Subst Abuse Treat. 2001;20(3):233–8.CrossRefPubMed
14.
Reid MS, Fallon B, Sonne S, Flammino F, Nunes EV, Jiang H, et al. Smoking cessation treatment in community-based substance abuse rehabilitation programs. J Subst Abuse Treat. 2008;35(1):68–77.CrossRefPubMed
15.
Shoptaw S, Rotheram‐Fuller E, Yang X, Frosch D, Nahom D, Jarvik ME, et al. Smoking cessation in methadone maintenance. Addiction. 2002;97(10):1317–28.CrossRefPubMed
16.
Stein MD, Weinstock MC, Herman DS, Anderson BJ, Anthony JL, Niaura R. A smoking cessation intervention for the methadone‐maintained. Addiction. 2006;101(4):599–607.CrossRefPubMed
17.
Sussman S. Smoking cessation among persons in recovery. Subst Use Misuse. 2002;37(8–10):1275–98.CrossRefPubMed
18.
Prochaska JJ, Delucchi K, Hall SM. A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. J Consult Clin Psychol. 2004;72(6):1144.CrossRefPubMed
19.
NSW Ministry of Health. The guide for the management of nicotine dependent inpatients. Gladesville: Better Health Centre; 2002.
20.
Fiore M. Treating tobacco use and dependence: 2008 update: clinical practice guideline. Collingdale: DIANE Publishing; 2008.
21.
Ratschen E, Britton J, Mcneill A. The smoking culture in psychiatry: time for change. Br J Psychiatry. 2011;198(1):6–7.CrossRefPubMed
22.
Hunt JJ, Cupertino AP, Garrett S, Friedmann PD, Richter KP. How is tobacco treatment provided during drug treatment? J Subst Abus Treat. 2012;42(1):4–15.CrossRef
23.
Walsh RA, Bowman JA, Tzelepis F, Lecathelinais C. Smoking cessation interventions in Australian drug treatment agencies: a national survey of attitudes and practices. Drug Alcohol Rev. 2005;24(3):235–44.CrossRefPubMed
24.
Bowman J, Walsh R. Smoking intervention within alcohol and other drug treatment services: a selective review with suggestions for practical management. Drug Alcohol Rev. 2003;22(1):73–82.CrossRefPubMed
25.
Currie SR, Nesbitt K, Wood C, Lawson A. Survey of smoking cessation services in Canadian addiction programs. J Subst Abus Treat. 2003;24(1):59–65.CrossRef
26.
Friedmann PD, Jiang L, Richter KP. Cigarette smoking cessation services in outpatient substance abuse treatment programs in the United States. J Subst Abus Treat. 2008;34(2):165–72.CrossRef
27.
Hall SM, Prochaska JJ. Treatment of smokers with co-occurring disorders: emphasis on integration in mental health and addiction treatment settings. Annu Rev Clin Psychol. 2009;5:409.CrossRefPubMedPubMedCentral
28.
Fiore MC, Keller PA, Curry SJ. Health system changes to facilitate the delivery of tobacco-dependence treatment. Am J Prev Med. 2007;33(6):S349–56.CrossRefPubMed
29.
Guydish J, Ziedonis D, Tajima B, Seward G, Passalacqua E, Chan M, et al. Addressing Tobacco Through Organizational Change (ATTOC) in residential addiction treatment settings. Drug Alcohol Depend. 2012;121(1):30–7.CrossRefPubMed
30.
Kalman D, Kim S, Digirolamo G, Smelson D, Ziedonis D. Addressing tobacco use disorder in smokers in early remission from alcohol dependence: the case for integrating smoking cessation services in substance use disorder treatment programs. Clin Psychol Rev. 2010;30(1):12–24.CrossRefPubMedPubMedCentral
31.
32.
33.
34.
35.
Freund M, Campbell E, Paul C, Sakrouge R, Lecathelinais C, Knight J, et al. Increasing hospital‐wide delivery of smoking cessation care for nicotine‐dependent in‐patients: a multi‐strategic intervention trial. Addiction. 2009;104(5):839–49.CrossRefPubMed
36.
Bonevski B, Bowman J, Richmond R, Bryant J, Wye P, Stockings E, et al. Turning of the tide: changing systems to address smoking for people with a mental illness. Mental Health Subst Use. 2011;4(2):116–29.CrossRef
37.
38.
Bonevski B, Sanson-Fisher R, Campbell E, Carruthers A, Reid A, Ireland M. Randomized controlled trial of a computer strategy to increase general practitioner preventive care. Prev Med. 1999;29(6):478–86.CrossRefPubMed
39.
Bonevski B, Bryant J, Paul C. Encouraging smoking cessation among disadvantaged groups: a qualitative study of the financial aspects of cessation. Drug Alcohol Rev. 2011;30(4):411–8.CrossRefPubMed
40.
Freund M, Campbell E, Paul C, Sakrouge R, Wiggers J. Smoking care provision in smoke-free hospitals in Australia. Prev Med. 2005;41(1):151–8.CrossRefPubMed
41.
Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan GE. Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res. 2003;5(1):13–25.CrossRefPubMed
42.
43.
Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J. Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict. 1989;84(7):791–9.CrossRefPubMed
44.
Bryant J, Bonevski B, Paul C. A survey of smoking prevalence and interest in quitting among social and community service organisation clients in Australia: a unique opportunity for reaching the disadvantaged. BMC Public Health. 2011;11(1):827.CrossRefPubMedPubMedCentral
45.
Bryant J, Bonevski B, Paul C, Lecathelinais C. Assessing smoking status in disadvantaged populations: is computer administered self report an accurate and acceptable measure? BMC Med Res Methodol. 2011;11(1):153.CrossRefPubMedPubMedCentral
46.
47.
Metadata
Title
An organisational change intervention for increasing the delivery of smoking cessation support in addiction treatment centres: study protocol for a randomized controlled trial
Authors
Billie Bonevski
Ashleigh Guillaumier
Anthony Shakeshaft
Michael Farrell
Flora Tzelepis
Scott Walsberger
Catherine D’Este
Chris Paul
Adrian Dunlop
Andrew Searles
Peter Kelly
Rae Fry
Robert Stirling
Carrie Fowlie
Eliza Skelton
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Trials / Issue 1/2016
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-016-1401-6

Other articles of this Issue 1/2016

Trials 1/2016 Go to the issue

Research

Exploring methods the for selection and integration of stakeholder views in the development of core outcome sets: a case study in reconstructive breast surgery

Study protocol

The incidence of training responsiveness to cardiorespiratory fitness and cardiometabolic measurements following individualized and standardized exercise prescription: study protocol for a randomized controlled trial

Study protocol

Impact of preoperative Vitamin D3 administration on postoperative hypocalcaemia in patients undergoing total thyroidectomy (HypoCalViD): study protocol for a randomized controlled trial

Research

The ethical issues regarding consent to clinical trials with pre-term or sick neonates: a systematic review (framework synthesis) of the analytical (theoretical/philosophical) research

Study protocol

Comparison of exenatide with biphasic insulin aspart 30 on glucose variability in type 2 diabetes: study protocol for a randomized controlled trial

Study protocol

Epidermal grafting versus split-thickness skin grafting for wound healing (EPIGRAAFT): study protocol for a randomised controlled trial